Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
10 Oct 2012
UCB Announces Third Research Collaboration With Harvard University
Read More
26 Sep 2012
UCB announces top-line phase 2 results for olokizumab in rheumatoid arthritis
Read More
24 Sep 2012
UCB sponsors several data presentations on epilepsy, including new real-life data on Vimpat® at the 10th European Congress on Epileptology
Read More
14 Sep 2012
In line with its strategy, UCB expands its biotechnology base in Belgium
Read More
10 Sep 2012
Transparency notification of Capital Research and Management Company and The Capital Group Companies
Read More
6 Sep 2012
Acquisition of own shares in the framework of employees’ long-term incentive plans
Read More
1 Aug 2012
UCB half year results 2012: on track for growth
Read More
16 Jul 2012
UCB Launches Neupro® in the U.S. to treat Parkinson’s Disease and Restless Legs Syndrome
Read More
28 Jun 2012
Acquisition of own shares
Read More
25 Jun 2012
UCB wins “Company Of the Year” at the European Mediscience Awards
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
57
Page
58
Page
59
Page
60
Current page
61
Page
62
Page
63
Page
64
Page
65
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss